UK health agency merger
This article was originally published in The Tan Sheet
Executive Summary
Medicines Control Agency, Medical Devices Agency will merge into single, as-yet-unnamed entity next April due to increasing convergence in drug, medical device fields, Department of Health announces June 13. Systems and processes by which drugs are licensed, medical devices are controlled will not be affected, but merger will include creation of chairman post to serve as agency's authoritative figurehead and oversee strategic management. Agency also will have a chief executive; current MCA Chief Exec Keith Jones, MD, is leaving his post in October...
You may also be interested in...
UK health agency
Medicines & Healthcare Products Regulatory Agency will become official April 1 with new Web site at http://www.mhra.gov.uk. MHRA will consist of Medicines Control Agency and Medical Devices Agency; merger was initiated in June 2002 to address convergence of drug, medical device fields (1"The Tan Sheet" June 17, 2002, In Brief)...
UK medicines agency head
Alasdair Breckenridge, chairman of the Medicines Control Agency's Committee on the Safety of Medicines, named chair-designate of UK's Medicines & Healthcare Products Regulatory Agency, Department of Health announces Nov. 28. MHRA will consist of MCA and Medical Devices Agency and will become official in April 2003 (1"The Tan Sheet" June 17, 2002, In Brief). One of Breckenridge's first responsibilities will be to help appoint a chief exec of MHRA; last day to submit applications for the post was Nov. 20...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”